European Medicines Company authorizes Pfizer vaccine to be used within the EU

A healthcare worker holds a coronavirus disease (COVID-19) vaccine bottle at the Dignity Health Glendale Memorial Hospital and Health Center in Glendale, California, United States on December 17, 2020.

Lucy Nicholson | Reuters

The European Medicines Agency on Monday approved Pfizer and BioNTech’s coronavirus vaccine for conditional use, opening the door to a vaccination program across the European Union.

“The EMA has recommended conditional marketing authorization for the Comirnaty vaccine developed by BioNTech and Pfizer to prevent 2019 coronavirus disease (COVID-19) in people aged 16 and older,” said a regulatory agency statement .

“The EMA’s scientific opinion paves the way for the first authorization for the placing on the market of a COVID-19 vaccine in the EU by the European Commission with all associated protective measures, controls and obligations,” said the agency.

This is breaking news. Please try again.

Comments are closed.